GLP-1 medicines may cut clot-related risks in chronically inflamed patients
In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism,…